Egg Enclosed In Shell Or A Part Thereof (e.g., Eggshell, Egg Yolk, Etc.) Patents (Class 424/581)
  • Patent number: 10918676
    Abstract: The present technology relates generally to formulations comprising egg white protein, methods of manufacturing egg protein formulations and uses for egg protein formulations. In particular, several embodiments are directed to egg protein formulations for oral administration in immunotherapy of subjects affected by egg allergies.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: February 16, 2021
    Assignee: Aimmune Therapeutics, Inc.
    Inventor: Howard V. Raff
  • Patent number: 10376550
    Abstract: A method of modulating inflammation in an organism, which includes administering to an organism a composition including a therapeutic amount of a hydrolyzed extract from the plant Biota orientalis. Several key components of the hydrolyzed extract of Biota orientalis have been identified that have also been shown to have an effect in dramatically reducing inflammatory responses.
    Type: Grant
    Filed: April 4, 2016
    Date of Patent: August 13, 2019
    Assignee: Dacy Tech Pty Ltd.
    Inventor: Dan Bright
  • Patent number: 10328021
    Abstract: The present invention relates to cosmetic compositions obtained or obtainable from Salmonidae hatching fluid, methods of producing said compositions and their use in various cosmetic applications to the skin, particularly for reducing or preventing the cosmetic appearance or prevalence of wrinkles, fine lines, hyperpigmentation, laxity, dry skin, scaling and/or transepidermal water loss in skin of a mammalian animal.
    Type: Grant
    Filed: June 25, 2012
    Date of Patent: June 25, 2019
    Assignee: AQUA BIO TECHNOLOGY ASA
    Inventors: Bernt T H. Walther, Hans Kristian Leren
  • Patent number: 10166215
    Abstract: The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.
    Type: Grant
    Filed: April 20, 2017
    Date of Patent: January 1, 2019
    Assignee: Zenith Epigenetics Ltd.
    Inventors: Shuang Liu, John Frederick Quinn, Bryan Cordell Duffy, Ruifang Wang, May Xiaowu Jiang, Gregory Scott Martin, He Zhao, Michael Ellis, Gregory Steven Wagner, Peter Ronald Young
  • Patent number: 9999616
    Abstract: The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.
    Type: Grant
    Filed: April 20, 2017
    Date of Patent: June 19, 2018
    Assignee: Zenith Epigenetics Ltd.
    Inventors: Shuang Liu, John Frederick Quinn, Bryan Cordell Duffy, Ruifang Wang, May Xiaowu Jiang, Gregory Scott Martin, He Zhao, Michael Ellis, Gregory Steven Wagner, Peter Ronald Young
  • Patent number: 9809750
    Abstract: A liquid crystal composition contains liquid crystals containing one kind of or two or more kinds of silicone surfactants, a phenyl-modified silicone oil and water. The liquid crystal composition of the present invention contains 5 to 95% by weight in total of one kind of or two or more kinds of silicone surfactants, 0.1 to 90% by weight of a phenyl-modified silicone oil and 0.1 to 90% by weight of water. The liquid crystal composition of the present invention can solubilize hydrophobic compounds having poor solubility (for example, hydrocarbon oils such as squalane, fatty acids such as oleic acid and lipoic acid and ester oils such as cetyl isooctanoate) and is thus useful, for example, as toiletry materials and cosmetic materials.
    Type: Grant
    Filed: September 29, 2010
    Date of Patent: November 7, 2017
    Assignee: Nanoegg Research Laboratories, Inc.
    Inventors: Yoko Yamaguchi, Yuji Yamashita, Takeshi Hamasaki
  • Publication number: 20150132402
    Abstract: The present invention provides a dietary supplement that promote the growth, repair, and maintenance of mammalian bone and joint connective tissue. In particular, the dietary supplement comprises a combination of at least one metal chelate and at least one chondroprotective agent.
    Type: Application
    Filed: January 23, 2015
    Publication date: May 14, 2015
    Inventors: Jeremy D. Moore, Thomas R. Hampton, Robert Harrell
  • Patent number: 8992996
    Abstract: A composition is provided that includes a fish spawn protein isolate. A natural product extract is also present that includes unsaturated fatty acids and sterols. An emulsifier is provided to form a mixture of the isolate and the extract. A composition is also provided that includes an egg hatching protein isolate and at least one biocide protective of isolate activity. An emulsifier forms a mixture with the isolate that has an aqueous phase buffered to a pH of between 5.6 and 7.9. A process of producing such a cosmetic has an emulsion or an aqueous phase that is buffered to a pH of between 5.5 and 7.9 prior to the addition of isolate to the emulsion. A process of improving skin appearance is provided that includes the application of the cosmetic to the skin at least three times per week to achieve the improvement of the skin appearance.
    Type: Grant
    Filed: May 29, 2013
    Date of Patent: March 31, 2015
    Assignee: Restorsea, LLC
    Inventors: Enrique P. Alabata, Patricia S. Pao
  • Patent number: 8968791
    Abstract: The present invention provides a dietary supplement that promote the growth, repair, and maintenance of mammalian bone and joint connective tissue. In particular, the dietary supplement comprises a combination of at least one metal chelate and at least one chondroprotective agent.
    Type: Grant
    Filed: May 30, 2008
    Date of Patent: March 3, 2015
    Assignee: Novus International, Inc.
    Inventors: Jeremy D. Moore, Thomas R. Hampton, Robert Harrell
  • Publication number: 20150056295
    Abstract: The invention describes methods and agents for improving cosmetic appearance, for promoting, improving or restoring health of cells and tissues, preferably skin, and more preferably, for restoring aged or damaged skin to a healthy appearance. The agents include compositions of cells, eggs, cell extracts, egg extracts, and extract components such as purified nucleic acids, polypeptides, lipids, carbohydrates or other natural products.
    Type: Application
    Filed: October 29, 2014
    Publication date: February 26, 2015
    Inventors: Runhild Gammelsaeter, Jan Remmereit
  • Publication number: 20140363519
    Abstract: To provide an activator of gene expression of molecular chaperone gene and applications thereof. This activator of gene expression of molecular chaperone gene contains an eggshell membrane component, for example, a powder containing eggshell membrane or a soluble eggshell membrane component. Moreover, the powder containing eggshell membrane used in the present invention may be a fine powder preferably having 6 ?m or less in the mean volume particle diameter of the fine powder containing eggshell membranes, and/or 20 ?m or less in the maximum volume particle diameter thereof, but not limited to these values.
    Type: Application
    Filed: November 27, 2013
    Publication date: December 11, 2014
    Applicants: The University of Tokyo, ALMADO Inc.
    Inventors: Yukio HASEBE, Yoriko ATOMI, Miho SHIMIZU
  • Publication number: 20140356450
    Abstract: Providing an agent for activating a sirtuin gene and an application thereof. The agent for activating a sirtuin gene is characterized to contain an egg shell membrane ingredient, for example an egg shell membrane-containing powder or soluble egg shell membrane ingredient.
    Type: Application
    Filed: November 27, 2013
    Publication date: December 4, 2014
    Applicants: ALMADO Inc., The University of Tokyo
    Inventors: Yoriko ATOMI, Miho SHIMIZU, Yukio HASEBE
  • Publication number: 20140348939
    Abstract: A wound care product in the form of a gel is provided, and contains protein from egg shell membrane. The gel is made by first hydrating the egg shell membrane powder and then adding carbomer to partially neutralize the egg shell membrane. The neutralization is completed with the addition of triethanolamine, so as to form a homogeneous gel with a smooth consistency. An antimicrobial compound and a tissue growth accelerator are added to the gel. The gel, infused with egg shell membrane, is applied directly to the wound tissue to form a barrier trapping the active ingredients adjacent the wound site and inhibiting penetration of outside bacteria into the wound site.
    Type: Application
    Filed: May 24, 2013
    Publication date: November 27, 2014
    Inventors: Robert C. Blaine, Thang D. Ngo
  • Publication number: 20140294961
    Abstract: The hepatoprotective agent contains eggshell membrane-containing fine powder, wherein the eggshell membrane-containing fine powder is eggshell membrane-containing fine powder having a volume mean particle diameter of 6 ?m or less and/or eggshell membrane-containing fine powder having a volume maximum particle diameter of 20 ?m or less. When fed with feed including eggshell membrane-containing fine powder with these values (sample C), the liver injury group (CCl4) caused a significant weight loss compared with the control group (control), but the test group ESM, the eggshell membrane-fed group (ESM) maintained the equal weight to the control group.
    Type: Application
    Filed: April 25, 2013
    Publication date: October 2, 2014
    Applicants: ALMADO Inc., The University of Tokyo
    Inventors: Hisanori KATO, HuiJuan JIA, Yukio HASEBE
  • Publication number: 20140255331
    Abstract: It comprises an egg preparation comprising a mixture of the yolk and the white extracted from a fertilized egg incubated for a period comprised between 18 hours and 36 hours, wherein the mixture of the yolk and white is in a ratio in which the amount of the white is comprised between 2% and 40% by volume of the yolk volume, useful as regenerating, analgesic and/or anti-inflammatory agent, as well as its preparation process. It also relates to functional foods, dietary supplements, and pharmaceutical or veterinary compositions containing the egg preparation. It also relates to cosmetic compositions comprising the egg preparation and to its use as skin care or hair or fur care agent.
    Type: Application
    Filed: May 18, 2012
    Publication date: September 11, 2014
    Applicant: OVIVITY GROUP, S.L.
    Inventor: Juan Cunill Aixelà
  • Publication number: 20140220088
    Abstract: The present invention relates to cosmetic compositions obtained or obtainable from Salmonidae hatching fluid, methods of producing said compositions and their use in various cosmetic applications to the skin, particularly for reducing or preventing the cosmetic appearance or prevalence of wrinkles, fine lines, hyperpigmentation, laxity, dry skin, scaling and/or transepidermal water loss in skin of a mammalian animal.
    Type: Application
    Filed: June 25, 2012
    Publication date: August 7, 2014
    Applicant: AQUA BIO TECHNOLOGY ASA
    Inventors: Bernt TH. Walther, Hans Kristian Leren
  • Publication number: 20140193516
    Abstract: In one aspect, the invention relates to methods for treating a disease or condition associated with abnormal glucose metabolism. In another aspect, the invention relates to a method for reducing incidence or progression of insulin-dependent diabetes mellitus. The methods include orally administering to a mammal in need thereof an effective amount of a composition, which includes a naturally occurring material derived from eggshell, eggshell membrane, or a combination thereof.
    Type: Application
    Filed: March 13, 2014
    Publication date: July 10, 2014
    Inventor: Kevin Ruff
  • Patent number: 8753609
    Abstract: A standardized, edible food containing a label for use in the measurement of gastric emptying by the quantification of marker excreted in the breath of the patient and methods of making the same using fluid bed granulation processing.
    Type: Grant
    Filed: June 10, 2009
    Date of Patent: June 17, 2014
    Assignee: Advanced Breathe Diagnostics, LLC
    Inventors: Kerry C. Bush, Stanley J. Konopka, Ronald W. Sanda
  • Publication number: 20140120175
    Abstract: Disclosed is a composition comprising MZ for use as a dietary supplement or food additive for oral consumption for improving the visual performance of a human subject.
    Type: Application
    Filed: December 2, 2013
    Publication date: May 1, 2014
    Applicant: HOWARD FOUNDATION HOLDINGS LIMITED
    Inventors: John Nolan, Stephen Beatty, James Loughman, Alan N. Howard, David Thurnham
  • Publication number: 20140023634
    Abstract: Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA either alone or in combination with other active constituents, including astaxanthin and polymeric hyaluronic acid or sodium hyaluronate (hyaluronan) in an oral dosage form.
    Type: Application
    Filed: September 5, 2013
    Publication date: January 23, 2014
    Applicant: U.S. NUTRACEUTICALS, LLC d/b/a Valensa International
    Inventors: John A. MINATELLI, W. Stephen Hill, Rudi E. Moerck
  • Publication number: 20130337080
    Abstract: The present invention provides a dietary supplement that promote the growth, repair, and maintenance of mammalian bone and joint connective tissue. In particular, the dietary supplement comprises a combination of at least one metal chelate and at least one chondroprotective agent.
    Type: Application
    Filed: January 9, 2012
    Publication date: December 19, 2013
    Applicant: ESM Technologies, LLC
    Inventors: Karen Wedekind, Kevin Ruff
  • Patent number: 8580315
    Abstract: The present invention relates to anti-inflammatory activity of eggshell membrane, processed eggshell membrane preparations and eggshell membrane isolates. The invention is directed to eggshell membrane compositions exhibiting anti-inflammatory activity as measured by effects on down-regulating pro-inflammatory plasma antigens in mammals that had orally ingested such compositions. This information supports the potential benefits from administration of naturally occurring material found in eggshell membrane, processed eggshell membrane, eggshell membrane isolates and combinations to reduce pain and inflammation associated with arthritis and other inflammatory conditions.
    Type: Grant
    Filed: March 7, 2007
    Date of Patent: November 12, 2013
    Assignee: ESM Technologies, LLC
    Inventors: Dale Paul DeVore, Frank Daniel Long
  • Publication number: 20130287756
    Abstract: Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found with krill oil and/or marine oil in combination with other active constituents, including astaxanthin and polymeric hyaluronic acid or sodium hyaluronate (hyaluronan) in an oral dosage form.
    Type: Application
    Filed: June 11, 2013
    Publication date: October 31, 2013
    Inventors: John A. MINATELLI, W. Stephen Hill, Swati Sebastian Thomas, Lingan Rajendran, Rudi E. Moerck
  • Publication number: 20130280343
    Abstract: A process, wherein food-producing livestock are administered cannabinoid receptor agonists, is used to induce physiological and/or behavioral effects in the livestock. Food products are then derived from the livestock.
    Type: Application
    Filed: April 20, 2012
    Publication date: October 24, 2013
    Inventor: Justin Lee Roettger
  • Publication number: 20130115304
    Abstract: The present invention relates to a method for modulating immune response in a subject, which comprises administering to the subject an effective amount of a composition comprising a yolk or yolk antibody obtained from an egg of a fowl which has been immunized using Helicobacter pylori as an antigen. In particular, the method of the invention is effective in enhancing production of IFN-?? and suppressing production of IL-4 and IL-5 in a subject. Also provided is a composition which comprises said yolk or yolk antibody in combination with polypore and chitosan.
    Type: Application
    Filed: December 26, 2012
    Publication date: May 9, 2013
    Applicant: ASIA HEPATO GENE CO.
    Inventor: ASIA HEPATO GENE CO.
  • Patent number: 8425943
    Abstract: The process for solubilizing proteinaceous material of the present invention includes subjecting the proteinaceous material to a sufficient amount of a basic solution to obtain a supernatant that has a basic pH and exposing the supernatant to the basic solution for a sufficient length of time and temperature for hydrolysis to occur. The process also includes cooling the mixture of the supernatant and proteinaceous material and optionally acidifying the mixture. This process may also include recovering the solubilized protein from the supernatant for use in various applications. Also provided herein is a composition of solubilized proteins from eggshell membrane obtained using processes of the present invention.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: April 23, 2013
    Assignee: Biova, L.L.C.
    Inventors: Ronald E. Strohbehn, Lisa R. Etzel, Jesse Figgins
  • Publication number: 20130089619
    Abstract: In one aspect, the invention relates to methods for treating a disease or condition associated with abnormal glucose metabolism. In another aspect, the invention relates to a method for reducing incidence or progression of insulin-dependent diabetes mellitus. The methods include orally administering to a mammal in need thereof an effective amount of a composition, which includes a naturally occurring material derived from eggshell, eggshell membrane, or a combination thereof.
    Type: Application
    Filed: April 12, 2011
    Publication date: April 11, 2013
    Inventor: Kevin J. Ruff
  • Publication number: 20130078315
    Abstract: Provided herein is a composition and a method for inhibiting bacterial growth.
    Type: Application
    Filed: November 2, 2012
    Publication date: March 28, 2013
    Applicant: BIOSYNERGY, INC.
    Inventor: BIOSYNERGY, INC.
  • Patent number: 8357663
    Abstract: Methods of promoting reproductive health in an animal by administering an effective amount of a composition containing at least one transfer factor are provided.
    Type: Grant
    Filed: November 30, 2008
    Date of Patent: January 22, 2013
    Assignee: The Ramaekers Family Trust
    Inventor: Joseph C. Ramaekers
  • Publication number: 20130011486
    Abstract: Disclosed is a composition comprising MZ for use as a dietary supplement or food additive for oral consumption for improving the visual performance of a human subject.
    Type: Application
    Filed: July 6, 2012
    Publication date: January 10, 2013
    Applicant: Howard Foundation Holdings Limited
    Inventors: John Nolan, Stephen Beatty, James Loughman, Alan N. Howard, David Thurnham
  • Publication number: 20120315300
    Abstract: The invention discloses a method of coating a medical device. The method includes applying a coating composition on the medical device to form a layer on the medical device. The coating composition includes one or more of one or more biological agents and heparin dissolved in a mixture of a first solvent and a second solvent. The first solvent and the second solvent have different evaporation temperatures. Subsequently, at least a part of one of the first solvent and the second solvent present in the coating composition is evaporated to create a plurality of pores in the layer. Thereafter, one or more drugs are deposited in the plurality of pores. When the medical device is positioned and expanded at a target site, the one or more drugs are released from the plurality of pores.
    Type: Application
    Filed: January 19, 2011
    Publication date: December 13, 2012
    Applicants: Envision Scientific Private Limited, Concept Medical Research Private limited
    Inventors: Manish Doshi, Divyesh Sherdiwala, Prakash Sojitra
  • Publication number: 20120276214
    Abstract: Provided is an infant nutrition comprising at least one protease inhibitor, a process for preparing such an infant nutrition and use of the infant nutrition for the treatment and/or prevention of childhood obesity and secondary disorders resulting from childhood obesity.
    Type: Application
    Filed: May 1, 2012
    Publication date: November 1, 2012
    Inventors: Katrien Maria Jozefa VAN LAERE, Bernardina Johanna Martina DELSING, Christopher BEERMANN, Rene John RAGGERS
  • Publication number: 20120237495
    Abstract: The process for solubilizing proteinaceous material of the present invention includes subjecting the proteinaceous material to a sufficient amount of a basic solution to obtain a supernatant that has a basic pH and exposing the supernatant to the basic solution for a sufficient length of time and temperature for hydrolysis to occur. The process also includes cooling the mixture of the supernatant and proteinaceous material and optionally acidifying the mixture. This process may also include recovering the solubilized protein from the supernatant for use in various applications. Also provided herein is a composition of solubilized proteins from eggshell membrane obtained using processes of the present invention.
    Type: Application
    Filed: May 31, 2012
    Publication date: September 20, 2012
    Applicant: BIOVA, L.L.C.
    Inventors: Ronald E. Strohbehn, Lisa R. Etzel, Jesse L Figgins
  • Patent number: 8246931
    Abstract: A method for using bird eggs to detect the presence of at least one botulinum toxin.
    Type: Grant
    Filed: July 23, 2009
    Date of Patent: August 21, 2012
    Assignee: The United States of America, as represented by the Secretary of Agriculture
    Inventors: Richard J. Buhr, Dianna V. Bourassa, Larry J. Richardson, Lynda C. Kelley, Nelson A. Cox, Jr., Robert W. Phillips
  • Patent number: 8211477
    Abstract: The process for solubilizing proteinaceous material of the present invention includes subjecting the proteinaceous material to a sufficient amount of a basic solution to obtain a supernatant that has a basic pH and exposing the supernatant to the basic solution for a sufficient length of time and temperature for hydrolysis to occur. The process also includes cooling the mixture of the supernatant and proteinaceous material and optionally acidifying the mixture. This process may also include recovering the solubilized protein from the supernatant for use in various applications. Also provided herein is a composition of solubilized proteins from eggshell membrane obtained using processes of the present invention.
    Type: Grant
    Filed: July 24, 2009
    Date of Patent: July 3, 2012
    Assignee: Biova, L.L.C.
    Inventors: Ronald E. Strohbehn, Lisa R. Etzel, Jesse I. Figgins
  • Patent number: 8197852
    Abstract: The process for solubilizing proteinaceous material of the present invention includes subjecting the proteinaceous material to a sufficient amount of a basic solution to obtain a supernatant that has a basic pH and exposing the supernatant to the basic solution for a sufficient length of time and temperature for hydrolysis to occur. The process also includes cooling the mixture of the supernatant and proteinaceous material and optionally acidifying the mixture. This process may also include recovering the solubilized protein from the supernatant for use in various applications. Also provided herein is a composition of solubilized proteins from eggshell membrane obtained using processes of the present invention.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: June 12, 2012
    Assignee: Biova, L.L.C.
    Inventors: Ronald E. Strohbehn, Lisa R. Etzel, Jesse Figgins
  • Patent number: 8197853
    Abstract: The process for solubilizing proteinaceous material of the present invention includes subjecting the proteinaceous material to a sufficient amount of a basic solution to obtain a supernatant that has a basic pH and exposing the supernatant to the basic solution for a sufficient length of time and temperature for hydrolysis to occur. The process also includes cooling the mixture of the supernatant and proteinaceous material and optionally acidifying the mixture. This process may also include recovering the solubilized protein from the supernatant for use in various applications. Also provided herein is a composition of solubilized proteins from eggshell membrane obtained using processes of the present invention.
    Type: Grant
    Filed: October 18, 2010
    Date of Patent: June 12, 2012
    Assignee: Biova, L.L.C.
    Inventors: Ronald E. Strohbehn, Lisa R. Etzel, Jesse Figgins
  • Publication number: 20120121680
    Abstract: Deicing products designed to deter ungulates are provided, along with methods of using those products to treat iced surfaces. The deicing product comprises a mixture of a deicer along with an ungulate repellent. The repellent can repel based on conditioned avoidance, fear, chemical irritation, and/or bad taste. The deicer can be a salt or a deicer solution. The invention is useful for deterring any ungulate that might be attracted to a component of the deicing product (e.g., the salt), but it is particularly useful for deterring deer.
    Type: Application
    Filed: October 18, 2011
    Publication date: May 17, 2012
    Applicant: NORTH AMERICAN SALT COMPANY
    Inventors: Neil Alexander Rosenburgh, Michelle Lee Daum, Jason Louis Bagley, Dan Pannell, Kristopher Shelite
  • Patent number: 8178315
    Abstract: A standardized, lyophilized edible food containing a biologically safe stable marker for use in the measurement of gastric emptying by the quantification of marker excreted in the breath of the patient.
    Type: Grant
    Filed: May 15, 2008
    Date of Patent: May 15, 2012
    Assignee: Advanced Breath Diagnostics, LLC
    Inventors: Kerry C. Bush, Keith D. Evans, Stanley J. Konopka
  • Patent number: 8173174
    Abstract: A solubilized protein composition is obtained from avian eggshell membrane without the use of proteolytic enzymes or cross-linking agents. The composition is essentially odor-free, has an ash content of less than 10% by weight of the composition and a protein content of at least 90% by weight of the composition including a mixture of solubilized proteins such as Type I collagen. Type V collagen. Type X collagen, elastin, lysozyme, ovotransferrin, desmosine, and/or B-N-acetylglucosaminidase, wherein the solubilized proteins are undenatured and retain biological activity.
    Type: Grant
    Filed: October 18, 2010
    Date of Patent: May 8, 2012
    Assignee: Biova, L.L.C.
    Inventors: Ronald E. Strohbehn, Lisa R. Etzel, Jesse Figgins
  • Publication number: 20120107411
    Abstract: The use of fertilised eggs, e.g. hen's eggs, or extracts thereof in the treatment of stress, such as perceived stress as well as in the use of such eggs to normalise Cortisol response in both chronically stressed and non stressed individuals. The invention further relates to the use of the eggs or an extract thereof in the treatment of anxiety, especially in chronically stressed individuals.
    Type: Application
    Filed: May 11, 2010
    Publication date: May 3, 2012
    Applicant: MED-EQ, AS
    Inventors: Nils Christian Mortensen, Kjell Hans Bakke
  • Publication number: 20120087987
    Abstract: The present disclosure relates to the combined use of two pesticides. A first pesticide composition provides an initial contact kill, and may form a barrier when applied to greasy surfaces. A second pesticide composition provides residual pesticidal activity on the surface. Methods of making and using the pesticide compositions are also provided.
    Type: Application
    Filed: October 12, 2011
    Publication date: April 12, 2012
    Applicant: ECOLAB USA INC.
    Inventors: Victor F. Man, S. John Barcay, Darren M. Jahnke, Yvonne M. Killeen
  • Publication number: 20120087964
    Abstract: The present disclosure relates to water dispersible granular pesticide compositions, and methods of making and using the compositions. The pesticide compositions include an inner layer including a first pesticide coated on to a substrate, and an outer layer comprising a second pesticide coated on the inner layer. The outer layer increases the water dispersibility of the granular composition, and protects the first pesticide against hydrolysis and photolysis.
    Type: Application
    Filed: October 12, 2011
    Publication date: April 12, 2012
    Applicant: ECOLAB USA INC.
    Inventors: Victor F. Man, Yvonne M. Killeen, Susan M. Viall
  • Publication number: 20120039796
    Abstract: A bio compatible free radical suspension, comprising of oxygen and electronically modified reaction intermediates, where a fluorocarbon is used as an inert medium for stabilization of reaction intermediates. A stabilized bio compatible electronically modified derivative suspension is produced by the subjecting a fluorocarbon to certain stressors, such as oxidizing agents, reactive intermediates, physiological gases, benzo-?-pyrone derivatives, ultrasonic-cavitation, electric fields, magnetic fields, UV radiation, active metal catalyst, surfactant reactants, buffers, electrolytes, glucose, glucose derivatives, for the purpose of inducing a cascading immune response.
    Type: Application
    Filed: August 13, 2011
    Publication date: February 16, 2012
    Inventor: Demetrios Markou
  • Publication number: 20120039973
    Abstract: The invention is a method of releasing essential oils over at least 30 days which includes encapsulating one or more essential oils in one or more carbohydrate and one or more protein. Additional embodiments include pesticides and/or additional repellents.
    Type: Application
    Filed: August 11, 2010
    Publication date: February 16, 2012
    Inventors: Paul Grlica, Steve Wisdom
  • Publication number: 20120034238
    Abstract: The present invention relates to a method for treating hepatitis virus infection comprising administering to a subject infected with a hepatitis virus an effective amount of a yolk or yolk antibody obtained from an egg of a fowl which has been immunized using Helicobacter pylori as an antigen. In particular, the method is effective in reducing virus titer and/or decreasing a level of glutamic oxaloacetic transaminase (GOT) or glutamic pyruvic transaminase (GPT) in the subject. Also provided is a composition for treating hepatitis virus infection which comprises the yolk or yolk antibody in combination with one or more supplemental ingredients such as Salviae Miltiorrhiza Radix, Oldennlandiae Hb., Zingiberis Radix, Ginseng Radix, Atractylodis Radix, Curcumae Radix, Angelicae Sinensis Radix, bee propolis, calcium lactate, soy proteins, probiotics, and grain bran.
    Type: Application
    Filed: August 3, 2011
    Publication date: February 9, 2012
    Applicant: ASIA HEPATO GENE CO.
    Inventor: David C. P. Chen
  • Publication number: 20120009198
    Abstract: The present invention relates to a method for modulating immune response in a subject, which comprises administering to the subject an effective amount of a composition comprising a yolk or yolk antibody obtained from an egg of a fowl which has been immunized using Helicobacter pylori as an antigen. In particular, the method of the invention is effective in enhancing production of IFN-? and suppressing production of IL-4 and IL-5 in a subject. Also provided is a composition which comprises said yolk or yolk antibody in combination with polypore and chitosan.
    Type: Application
    Filed: July 7, 2010
    Publication date: January 12, 2012
    Applicant: ASIA HEPATO GENE CO.
    Inventors: David C. P. Chen, Yi-Shu Chung
  • Publication number: 20110305773
    Abstract: The present invention relates to the use of an antisecretory protein or a derivative, homologue, and/or fragment thereof, having antisecretory activity, and/or a pharmaceutically active salt thereof, for the manufacture of a pharmaceutical composition and/or a medical food for the treatment and/or prevention of compartment syndrome. A compartment syndrome may be caused by or a cause of a variety of other conditions which are also encompassed by the present invention, such as viral and bacterial infections. Furthermore, the invention relates to a method for the treatment and/or prevention of compartment syndrome in a mammal in need thereof.
    Type: Application
    Filed: February 11, 2011
    Publication date: December 15, 2011
    Inventors: Hans-Arne HANSSON, Stefan LANGE, Eva JENNISCHE, Tomas BERGSTRÖM
  • Publication number: 20110171265
    Abstract: The invention relates to a composition for storage and development of eggs from helminthes parasites, where the composition further comprises a liquid carrier having a pH value of below 7 at a temperature from 10 C to ambient temperature. The liquid carrier can be sulphuric acid, H2SO4 with a Ph in the range from 0 to 2, and antibiotics can be added. The invention further relates to a method for treating, ameliorating, prophylactic or curative, or autoimmune or allergic disease in an individual animal or man, using eggs being separated from the composition. The present invention also relates to methods for isolation, embryonation and preservation of eggs of helminthic parasite, and to a method for producing a pharmaceutical composition comprising a helminthic parasite preparation. The helminthic parasite eggs may be from the pig whipworm; Trichuris suis ova (TSO).
    Type: Application
    Filed: March 11, 2011
    Publication date: July 14, 2011
    Inventors: Christian Mollin Outzen Kapel, Allan Roepstorff, Stig Milan Thamsborg
  • Publication number: 20110171187
    Abstract: The present invention provides a dietary supplement that promote the growth, repair, and maintenance of mammalian bone and joint connective tissue. In particular, the dietary supplement comprises a combination of at least one metal chelate and at least one chondroprotective agent.
    Type: Application
    Filed: May 30, 2008
    Publication date: July 14, 2011
    Applicant: Novus International, Inc.
    Inventors: Jeremy D. Moore, Thomas R. Hampton, Robert Harrell